Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Methanesulfonic Acid | HCID 6395 | — |
| Edukt | Eprosartan | HCID 5281037 | — |
| Lösungsmittel | Acetic Acid | HCID 176 | — |
| Produkt | Eprosartan Mesylate | HCID 5282474 | — |
Reaktionsschritte
An embodiment of the present invention is as follows: eprosartan is dissolved or suspended in glacial acetic acid, then methanesulfonic acid is added and stirred to obtain a solution of eprosartan mesylate in glacial acetic acid, the precipitated solid is stirred and filtered to obtain a solid of eprosartan mesylate, or glaicial acetic acid is concentrated to dry to obtain a solid of eprosartan mesylate, or an organic ester solvent is added dropwise to the glacial acetic acid under stirring to precipitate crystal and separate to obtain a solid of eprosartan mesylate, wherein the ratio of eprosartan (mass, g): methanesulfonic acid (mass, g): glacial acetic acid (volume, ml) is 1:0.1-5.0:1-15, and the temperature of reaction is 10° C.-110° C.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US08546585B2 |
|---|
| Quelldatensatz | uspto-grants-2013_10 |
|---|
| ORD ID | ord-92fcf26e3c7047f6bae52ea452360d6e |
|---|
| Quellennotiz | uspto-grants-2013_10 |
|---|